Is low dose aspirin associated with a reduced risk of overall cancer among the French population (ASPIK)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/24723
• EU PAS number:
  EUPAS24699
• Study ID:
  24723
• Official title and acronym:
  Is low dose aspirin associated with a reduced risk of overall cancer among the French population (ASPIK)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study status:
  Ongoing

Research institution and networks

Institutions

Centre de pharmaco-épidémiologie de l'APHP

Study timelines

Date when funding contract was signed

Planned: 03/02/2015

Actual: 03/02/2015

Study start date

Planned: 02/01/2017

Actual: 02/01/2017

Date of final study report

Planned: 01/10/2018

Sources of funding

Other

More details on funding

Paris Diderot University, PHRC-k

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable